Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 9
Submit an article Journal homepage
572
Views
14
CrossRef citations to date
0
Altmetric
Letters to the Editor

Rituximab–lenalidomide–dexamethasone induces complete and durable remission in relapsed refractory diffuse large B-cell non-Hodgkin lymphoma

Vadim IvanovDepartment of Hematology, Institute Paoli-Calmettes, Marseille, FranceCorrespondence[email protected]
,
Emeline TabouretDepartment of Hematology, Institute Paoli-Calmettes, Marseille, France
,
Guillaume ChutoDepartment of Nuclear Medicine, Institute Paoli-Calmettes, Marseille, France
,
Bruno ChetailleDepartment of Pathology, Institute Paoli-Calmettes, Marseille, France
,
Hacène FezouiHopital Font Pré, Toulon, France
,
Diane CosoDepartment of Hematology, Institute Paoli-Calmettes, Marseille, France
,
Jerome ReyDepartment of Hematology, Institute Paoli-Calmettes, Marseille, France
,
Therese Aurran-SchleinitzDepartment of Hematology, Institute Paoli-Calmettes, Marseille, France
,
Jean Marc SchianoDepartment of Hematology, Institute Paoli-Calmettes, Marseille, France
,
Anne Marie StoppaDepartment of Hematology, Institute Paoli-Calmettes, Marseille, France
,
Didier Blaise
&
Reda BouabdallahDepartment of Hematology, Institute Paoli-Calmettes, Marseille, France
 show all
Pages 1-3 | Published online: 14 Jul 2010

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Vadim Ivanov, Diane Coso, Bruno Chetaille, Benjamin Esterni, Daniel Olive, Therese Aurran-Schleinitz, Jean Marc Schiano, Anne-Marie Stoppa, Florence Broussais-Guillaumot, Didier Blaise & Reda Bouabdallah. (2014) Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:11, pages 2508-2513.
Read now
Peter H Wiernik. (2013) Lenalidomide in lymphomas and chronic lymphocytic leukemia. Expert Opinion on Pharmacotherapy 14:4, pages 475-488.
Read now
Ahmad S Halwani & Brian K Link. (2011) Chemotherapy and antibody combinations for relapsed/refractory non-Hodgkin’s lymphoma. Expert Review of Anticancer Therapy 11:3, pages 443-455.
Read now

Articles from other publishers (11)

Xiaoyan Wang, Lu Yu, Xinlu Jiang & Kaiyang Ding. (2023) Real‐world data for lenalidomide maintenance in responding patients of diffuse large B‐cell lymphoma . Cancer Medicine 12:9, pages 10553-10562.
Crossref
Brian G. Bazzell, Lydia L. Benitez, Bernard L. Marini, Anthony J. Perissinotti, Tycel J. Phillips & Victoria R. Nachar. (2021) Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 21:5, pages 295-308.
Crossref
Jennifer K Lue & Owen A O'Connor. (2020) A perspective on improving the R-CHOP regimen: from Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise. The Lancet Haematology 7:11, pages e838-e850.
Crossref
G. Iacoboni, E. Zucca, M. Ghielmini & A. Stathis. (2018) Methodology of clinical trials evaluating the incorporation of new drugs in the first-line treatment of patients with diffuse large B-cell lymphoma (DLBCL): a critical review. Annals of Oncology 29:5, pages 1120-1129.
Crossref
Catherine ThieblemontHervé TillyMaria Gomes da SilvaRene-Olivier CasasnovasChristophe FruchartFranck MorschhauserCorinne HaiounJulien LazaroviciAnida GrosickaAurore PerrotJudith TrotmanCatherine SebbanDolores CaballeroRichard GreilKoen van EygenAmos M. CohenHugo GonzalezReda BouabdallahLucie ObericBernadette CorrontBachra ChoufiArmando Lopez-GuillermoJohn CatalanoAchiel Van HoofJosette BriereJose CabeçadasGilles SallesPhilippe GaulardAndre BoslyBertrand Coiffier. (2017) Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. Journal of Clinical Oncology 35:22, pages 2473-2481.
Crossref
Grzegorz S. NowakowskiBetsy LaPlantWilliam R. MaconCraig B. ReederJames M. ForanGarth D. NelsonCarrie A. ThompsonCandido E. RiveraDavid J. InwardsIvana N. MicallefPatrick B. JohnstonLuis F. PorrataStephen M. AnsellRandy D. GascoyneThomas M. HabermannThomas E. Witzig. (2015) Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study. Journal of Clinical Oncology 33:3, pages 251-257.
Crossref
Olivera Tarabar, Bojana Cikota-Aleksić, Ljiljana Tukić, Nenad Milanović, Aleksandar Aleksić & Zvonko Magić. (2013) Association of interleukin-10, tumor necrosis factor-α and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas. International Journal of Clinical Oncology 19:1, pages 186-192.
Crossref
Maria Cosenza, Monica Civallero, Giulia Grisendi, Luigi Marcheselli, Erika Roat, Alessia Bari & Stefano Sacchi. (2012) Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines. Annals of Hematology 91:10, pages 1613-1622.
Crossref
Annalisa Chiappella & Umberto Vitolo. (2012) Lenalidomide in Diffuse Large B-Cell Lymphomas. Advances in Hematology 2012, pages 1-5.
Crossref
G S Nowakowski, B LaPlant, T M Habermann, C E Rivera, W R Macon, D J Inwards, I N Micallef, P B Johnston, L F Porrata, S M Ansell, R R Klebig, C B Reeder & T E Witzig. (2011) Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study. Leukemia 25:12, pages 1877-1881.
Crossref
Mathieu Wémeau, Jordan Gauthier, Xavier Leleu & Ibrahim Yakoub-Agha. (2011) IMiD en hématologie. Bulletin du Cancer 98:8, pages 879-887.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.